📢 Breaking news: our 8th call for proposals is now live! We're looking for solutions for: 🏙️ Tackling #HeartDisease in cities 🦴 Big data and #osteoarthritis 💡 Regulatory #sandboxes to support innovation 🤒 Patient-centred endpoints from digital technologies ⏰Deadline for short proposals: 10 October 2024 ➡️ More info: https://europa.eu/!fqGjrV #IHITransformingHealth #HealthResearch #ResearchFunding #HorizonEU COCIR EFPIA - European Federation of Pharmaceutical Industries and Associations EuropaBio - the European Association for Bioindustries MedTech Europe Vaccines Europe EU Science, Research and Innovation
Innovative Health Initiative (IHI)
Research Services
Brussels, - 19,265 followers
We’re an EU public-private partnership funding health research & innovation. We also manage IMI projects.
About us
The Innovative Health Initiative (IHI) aims to translate health research and innovation into real benefits for patients and society, and ensure that Europe remains at the cutting edge of interdisciplinary, sustainable, patient-centric health research. Health research and care increasingly involve diverse sectors. By supporting projects that bring these sectors together, IHI will pave the way for a more integrated approach to health care, covering prevention, diagnosis, treatment, and disease management. IHI is a partnership between the European Union and European industry associations representing the pharmaceutical, medical technology, biotechnology, digital health and vaccine industries, namely COCIR, EFPIA (including Vaccines Europe), EuropaBio, and MedTech Europe. IHI’s total budget is EUR 2.4 billion. Half of this comes from Horizon Europe, the EU’s research and innovation programme. The IHI industry partners have committed EUR 1 billion to IHI, and a further EUR 200 million can be committed by other organisations that decide to become Contributing Partners. IHI builds on the successes of the Innovative Medicines Initiative (IMI), which ran from 2008 to 2021. The IHI Programme Office continues to manage and promote projects launched under IMI. Follow us on Twitter at @IHIEurope
- Website
-
http://www.ihi.europa.eu
External link for Innovative Health Initiative (IHI)
- Industry
- Research Services
- Company size
- 51-200 employees
- Headquarters
- Brussels, -
- Type
- Partnership
- Founded
- 2021
Locations
-
Primary
Brussels, - 1049, BE
Employees at Innovative Health Initiative (IHI)
Updates
-
Innovative Health Initiative (IHI) reposted this
In a few months, the VALUE-Dx project is coming to an end. To honour this occasion, we are hosting a closing conference on 4 - 5 September in Valencia, Spain. During the event, we will look back on the tremendous journey, discuss the final results and look forward to the possible continuation of the work. There will also be ample room to interact and share ideas with invited stakeholders outside of the VALUE-Dx consortium. Find out more about the programme here ➡️ https://bit.ly/4ffilUD #AMR #diagnostics
-
Innovative Health Initiative (IHI) reposted this
🔐Bigpicture partners sign pioneering Data Sharing Agreement!🔐 We are excited to announce that all Bigpicture partners have signed the new Data Sharing Agreement (DSA), a major milestone for secure and responsible data sharing under GDPR. The DSA is fundamental for Bigpicture's repository. Jan-Willem Boiten, co-lead WP5, and senior program manager at Lygature, says, "The DSA sets out all necessary safeguards and clearly defines the roles and responsibilities related to data sharing." 🔗Read more: https://t.ly/kGtKH #Bigpicture #DataSharing #GDPR #Research #Collaboration #Milestone
-
-
Innovative Health Initiative (IHI) reposted this
We are excited to share the latest publication on immune toxicity associated with Interleukin-2 (IL-2) immune therapy! 📰 Well done to Charline Sommer and all co-authors 👏
🚀 Publication Alert! 🚀 I am thrilled to share our latest research on immune toxicity associated with Interleukin-2 (IL-2) immune therapy, a collaborative effort with Fraunhofer ITEM and the Universitéit Lëtzebuerg (University of Luxembourg) as part of the imSAVAR consortium. Our study explores how continuous IL-2 stimulation affects IL-2 receptor (IL-2R) regulation in human lymphocytes. 🔬 Key Insights: - High-dose IL-2 significantly reduces IL-2Rβ surface expression on T cells, impairing IL-2R signaling. - Elevated IL-2Rα baseline expression correlates with this impairment. - NK cell IL-2R signaling remains stable, while CD4 T cells, especially regulatory T cells, are more affected than CD8 T cells. These findings resemble the cellular changes seen in patients with IL-2Rβ mutations and highlight the critical need to monitor IL-2R signaling to manage adverse events during IL-2 therapy. 🔗 https://lnkd.in/eMRA-PSY A special thanks to all the co-authors for their invaluable contributions: Sophie Jacob, Tonia Bargmann, Muhammad Shoaib, PhD, Basel Alshaikhdeeb, Venkata Satagopam, Susann Dehmel, Vanessa Neuhaus, Armin Braun, and Katherina Sewald. Together, we are paving the way for safer and more effective immune therapies! #Immunotherapy #IL2 #NKcells #Tcells #Tregs #Collaboration
Bridging therapy-induced phenotypes and genetic immune dysregulation to study interleukin-2-induced immunotoxicology
sciencedirect.com
-
Applying for IHI call 8? Getting informed about who we are and what we are looking for is key to preparing a successful proposal, so make sure you watch the recordings of the webinars on your topic plus our rules and procedures! 💻 https://europa.eu/!wqJRJv #HorizonEU
-
-
Innovative Health Initiative (IHI) reposted this
***EUbOPEN opens its gates to a library of chemical compounds*** Enabling and unlocking biology in the OPEN (#EUbOPEN), a project of the Innovative Medicines Initiative (IMI), is an international consortium which is lead by Prof. Dr. Stefan Knapp from the Goethe-Universität Frankfurt. The Innovative Health Initiative (IHI) recognized EUbOPEN as a research highlight in its new brochure “IHI 2023 In Focus“. When developing new medicines, scientists aim to understand the underlying causes of #diseases. To achieve this, they study the role of different #proteins involved in the disease process. This requires chemical compounds that can alter or block the action of individual proteins. By the end of 2023, the EUbOPEN Gateway provided scientists with access to a library of 2300 precisely annotated chemical compounds covering approximately 850 different proteins. The EUbOPEN team’s goal is to create the largest and most deeply characterized open collection of #chemical modulators for protein function. Additionally, 88 high-quality probe compounds, co-developed by academics and #pharmaceutical industries, are now available to the global scientific community. These initiatives empower researchers in academia and industry to design #drugs that target specific disease-related proteins and enhance our understanding of disease mechanisms. You will find further information here: https://lnkd.in/dhu5YA6y
-
-
Innovative Health Initiative (IHI) reposted this
Antimicrobial resistance is a major health threat, causing 865,767 infections and 38,710 deaths in Europe in 2019 alone. Explore the burden of AMR for health-technology assessment in the paper by PrIMAVeRa project: https://lnkd.in/eWqfgSPJ. #AMRGlobalChallenge #SummerReading #OpenAccess Innovative Health Initiative (IHI) ERA4TB RespiriTB RespiriNTM UNITE4TB GSK Uppsala University BIOCOM Interrelations GmbH Universidad Carlos III de Madrid Lygature European Vaccine Initiative (EVI) BioVersys AG
-
-
Innovative Health Initiative (IHI) reposted this
Mark your calendars, conect4children is delighted to be a part of the “Better Medicines for Children” happening this October 📅! Organised by the EFGCP - European Forum for Good Clinical Practice this year’s theme is “Common issues in clinical development amplified in paediatric drug development”. Over 2 days, speakers and experts from #paediatricmedicine and #clinicaltrials will discuss child-centric medicine 🧒, the inclusion of pregnant people in clinical trials 🤰, data in paediatric #drugdevelopment 💊 and more. Read the programme and more conference details here: https://lnkd.in/eKrhEpd3 #conect4children #c4c #paediatricclinicaltrails #conference #research
Conference: EFGCP Better Medicines for Children Conference 2024
efgcp.eu
-
Innovative Health Initiative (IHI) reposted this
Health research collaborations mean sharing data – we can deliver faster if we identify and remove obstacles early. Capturing the experience of scientists who have travelled this road, IHI and EFPIA have put together a #Data #Sharing #Playbook. It offers practical solutions to common data sharing challenges, enabling researchers to focus on what matters most – advancing medical science. Explore the Playbook and join us on 4 September for a masterclass on how to facilitate data sharing ➡ https://bit.ly/46hVGmp #IHITransformingHealth #WeWontRest
-
A great opportunity to contribute to the work of our sister partnership Global Health EDCTP3 👇
📢 Call for expression of interest for the selection of members of the Scientific Committee! ℹ️ The Scientific Committee is the scientific advisory body of Global Health EDCTP3. ⏰ Applications must be sent by 30 September and include: ✅ A cover letter ✅ A curriculum vitae Follow the link below to have an overview of the tasks and requirements 👇 🔗 https://lnkd.in/dtDGT97c -------- EU Science, Research and Innovation Africa CDC Paulo Ferrinho Claudia Filippone Electra Gizeli John Gyapong Martin Meremikwu Keymanthri Moodley Juliet Nabyonga-Orem Meta Roestenberg Christine Stabell Benn Marleen Temmerman Nicki Tiffin Irene Norstedt Glaudina Loots European & Developing Countries Clinical Trials Partnership Dr Jean Marie Vianney Habarugira Liesbet De Cock Lara Pandya Michael Makanga Aleksandra Conversano
-